ENDRA Life Sciences (NDRA) Gross Profit (2016 - 2018)

ENDRA Life Sciences (NDRA) has 3 years of Gross Profit data on file, last reported at $6174.0 in Q1 2018.

• Gross Profit for Q1 2018 came in at $6174.0, changed N/A year-over-year; the trailing twelve-month figure through Dec 2018 was $6174.0 (down 96.55% YoY), and the FY2018 annual result was $6174.0, down 96.55% from the prior year.
• Gross Profit grew to $6174.0 in Q1 2018 per NDRA's latest filing, from $3765.0 in the prior quarter.
• Over five years, Gross Profit peaked at $279704.0 in Q4 2016 and troughed at $3765.0 in Q4 2017.
• A 3-year average of $92943.6 and a median of $6345.0 in 2017 frame the typical range for Gross Profit.
• On a YoY basis, Gross Profit climbed as much as 98.65% in 2017 and fell as far as 98.65% in 2017.
• A 3-year view of Gross Profit shows it stood at $279704.0 in 2016, then slumped by 98.65% to $3765.0 in 2017, then jumped by 63.98% to $6174.0 in 2018.
• Business Quant data shows NDRA's Gross Profit at $6174.0 in Q1 2018, $3765.0 in Q4 2017, and $168730.0 in Q3 2017.